Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
ACRS
8 quarters
Position history for JPMorgan Chase & Co.'s holdings in Aclaris Therapeutics, Inc.
Yes. JPMorgan Chase holds 468,964 shares of ACRS (Aclaris Therapeutics), worth $2.4M, as of its Q2 2026 13F filing. It reduced the position by 17,669 shares (-3.6%) from Q1 2026. JPMorgan Chase has held ACRS in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$2.4M
Current Shares
468,964
Total Value Change
+$2.3M
Total Shares Change
+460,488
Quarter-by-Quarter History
Other major holders of ACRS: Wellington Management Group LLP, Adage Capital Partners GP, L.L.C.